Aim: To assess the accuracy of the Dexcom G6 CGM system during elective abdominal surgery.
Methods: Twenty adults with (pre-)diabetes scheduled for abdominal surgery (>2h) (5 females, age 69±13 yrs, BMI 27.3±6.6 kg/m2, HbA1c 7.0±1.3%) wore the Dexcom G6 sensor from 7±2 days preoperatively until hospital discharge. Reference capillary glucose values were obtained every 20min from induction of anaesthesia until 2h post-surgery using the Accu-Chek® Inform II meter. The primary endpoint was the mean absolute relative difference (ARD) between sensor and reference method.
Results: Mean±SD operating time was 306±170min and included pancreas/liver (45%), upper GI (10%), lower GI (40%) and kidney (5%) surgeries. The mean±SD and median [interquartile range] ARD of 523 paired CGM/reference values were 12.7±8.7% and 10.4% [4.3%, 19.7%], respectively. A total of 99.4% pairs were in Clarke error grid Zones A or B (A, 76.5%, B 22.9%, Figure 1). Overall, 65.8% of sensor readings were within the limits specified by the ISO 15197:2013 norm. Sensor readings were available for 98.6% [95.9%, 100%] of the perioperative time. Intraoperative sensor replacement was required in one instance. There were no adverse device effects.
Conclusion: Perioperative use of the Dexcom G6 system showed satisfying accuracy, opening new avenues for perioperative diabetes care.
A. Tripyla: None. D. Herzig: None. C. Nakas: None. J. Dehais: None. A. Andreou: None. F. Amiet: None. B. Gloor: None. A. Vogt: None. L. Bally: None.
Dexcom, Inc. (HOS-2019-005)